NCT02266771View on ClinicalTrials.gov

Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2017

Study Completion Date

December 31, 2017

Conditions
Wounds and Injuries
Interventions
DEVICE

NPWT with Instillation

Kinetic Concepts Inc. V.A.C Ulta Negative Pressure Wound Therapy System with V.A.C. VeraFlo Instillation

DEVICE

NPWT

Kinetic Concepts Inc. V.A.C Ulta Negative Pressure Wound Therapy System

Trial Locations (1)

21215

Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, LifeBridge Health, Baltimore

Sponsors

Lead Sponsor

LifeBridge Health
All Listed Sponsors
collaborator

Kinetic Concepts, Inc.

INDUSTRY

lead

LifeBridge Health

OTHER

NCT02266771 - Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice | Biotech Hunter | Biotech Hunter